Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: The BASALT randomized controlled trial

JAMA

Volumn 308, Issue 10, 2012, Pages 987-997

  Calhoun, William J ^a   Ameredes, Bill T ^a   King, Tonya S ^b   Icitovic, Nikolina ^b   Bleecker, Eugene R ^c   Castro, Mario ^d   Cherniack, Reuben M ^e   Chinchilli, Vernon M ^b   Craig, Timothy ^b   Denlinger, Loren ^f   DiMango, Emily A ^g   Engle, Linda L ^b   Fahy, John V ^h   Grant, J Andrew ^a   Israel, Elliot ⁱ   Jarjour, Nizar ^f   Kazani, Shamsah D ⁱ   Kraft, Monica ^j   Kunselman, Susan J ^b   Lazarus, Stephen C ^h   Lemanske, Robert F ^f   Lugogo, Njira ^j   Martin, Richard J ^e   Meyers, Deborah A ^c   Moore, Wendy C ^c   Pascual, Rodolfo ^c   Peters, Stephen P ^c   Ramsdell, Joe ^k   Sorkness, Christine A ^f   Sutherland, E Rand ^e   Szefler, Stanley J ^e   Wasserman, Stephen I ^k   Walter, Michael J ^d   Wechsler, Michael E ⁱ   Boushey, Homer A ^h,l   more..

^a University of Texas Medical Branch School of Medicine   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DEPARTMENT OF MEDICINE   (United States)

^f University of Wisconsin Health   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^l UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BIOLOGICAL MARKER; CORTICOSTEROID; NITRIC OXIDE; PLACEBO; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT PLANNING;

EID: 84866129261     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/2012.jama.10893     Document Type: Article

References (23)

1. National Asthma Education and Prevention Program Expert Panel. Report 3: Guidelines for the Diagnosis and Management of Asthma. Rockville, MD: National Heart, Lung, and Blood Institute; 2007. NIH Publication 08-4051.
2. Global Initiative for Asthma. Global strategy for asthma management and prevention. http://www.ginasthma.org/guidelines-gina-report-global-strategy-for- asthma-management.html. Accessibility verified August 7, 2012.
3. Sutherland ER. Nocturnal asthma. J Allergy Clin Immunol. 2005;116(6):1179-1186.
4. Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults. Lancet. 2008;372(9643):1065-1072.
5. Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352(21):2163-2173.
6. Brightling CE, Green RH, Pavord ID. Biomarkers predicting response to corticosteroid therapy in asthma. Treat Respir Med. 2005;4(5):309-316.
7. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts. Lancet. 2002;360(9347):1715-1721.
8. Deykin A, Lazarus SC, Fahy JV, et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol. 2005;115(4):720-727.
9. Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med. 1999;159(4 pt 1):1043-1051.
10. Leuppi JD, Tandjung R, Anderson SD, et al. Prediction of treatment-response to inhaled corticosteroids bymannitol-challenge test in COPD. Pulm Pharmacol Ther. 2005;18(2):83-88.
11. Boushey HA, Sorkness CA, King TS, et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med. 2005;352(15):1519- 1528.
12. Papi A, Canonica GW, Maestrelli P, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med. 2007;356(20):2040-2052.
13. O'Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171(2):129-136.
14. Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med. 2010;363(18):1715- 1726.
15. Juniper EF, Svensson K, Mörk A-C, Ståhl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99(5):553-558.
16. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis. 1993;147(4):832-838.
17. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343(15):1054-1063.
18. van Den Toorn LM, Prins JB, Overbeek SE, et al. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2000;162(3 pt 1):953-957.
19. Oborne J, Mortimer K, Hubbard RB, et al. Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations. Am J Respir Crit Care Med. 2009;180(7):598-602.
20. Hardie GE, Janson S, Gold WM, et al. Ethnic differences. Chest. 2000;117(4):935-943.
21. Fritz GK, McQuaid EL, Kopel SJ, et al. Ethnic differences in perception of lung function. Am J Respir Crit Care Med. 2010;182(1):12-18.
22. Burchard EG, Avila PC, Nazario S, et al. Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med. 2004;169(3):386-392.
23. Choudhry S, Ung N, Avila PC, et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med. 2005;171(6):563-570.